| 內容註: |
Part I: General Information -- CHAPTER 1: The Consultative Process, Craig S. Kitchens, MD -- CHAPTER 2: A Systematic Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing, Craig Kessler, MD, Nushmia Khokhar, MD, Minetta Liu, MD -- CHAPTER 3: Endothelium William C. Aird, MD -- Part II: Hemorrhagic Processes -- CHAPTER 4: Hemophilia A and B, Lisa N. Boggio, MS, MD, Craig M. Kessler, MD -- CHAPTER 5: Less Common Congenital Disorders of Hemostasis, Harold R. Roberts, MD, Miguel A. Escobar, MD -- CHAPTER 6: Non-hemophilic inhibitors of coagulation, Bruce Ewenstein, MD, PhD -- CHAPTER 7: von Willebrand Disease, Margaret E. Rick, MD -- CHAPTER 8: General aspects of thrombocytopenia, platelet transfusions and platelet growth factors, David Kuter, MD -- CHAPTER 9: Immune Thrombocytopenic Purpura, James N. George, MD, Kiarash Kojouri, MD -- CHAPTER 10:Congenital and Acquired Disorders of Platelet Function and Number, Shawn Jobe, MD, PhD, Jorge Di Paola, MD -- CHAPTER 11: Purpura and Other Hematovascular Disoders, Marc Zumberg, MD, Craig S. Kitchens, MD -- CHAPTER 12: Disseminated Intravascular Coagulation, Carrie LaBelle, MD, Craig S. Kitchens, MD -- CHAPTER 13: The cross-talk of inflammation and coagulation in infectious disease and their value in disseminated intravascular coagulation, Eefje Jong, MD, Eric C.M. van Gorp, MD, Marcel Levi, MD, Hugo ten Cate, MD -- Part III: Thrombotic Processes -- CHAPTER 14: Thrombophilia: Clinical and Laboratory Assessment and Management, John A. Heit, MD -- CHAPTER 15: Deep Vein Thrombosis and Pulmonary Embolism, Samuel Z. Goldhaber, MD -- CHAPTER 16: Venous Thromboses at Unusual Sites, Marc S. Zumberg MD, Craig S. Kitchens, MD -- CHAPTER 17: Prevention, Diagnosis, and Treatment of the Postphlebitic Syndrome, Reagan W. Quan, MD, David L. Gillespie, MD -- CHAPTER 18: Thrombocytosis: essential thrombocythemia vs. reactive etiologies, Craig M. Kessler, MD, Jan Jacques Michiels, MD, PhD -- CHAPTER 19: The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management, Jacob Rand, MD, Miles B. Levin, MD, Barbara M. Alving MD -- CHAPTER 20: Hemostatic aspects of cardiovascular medicine, Richard C. Becker, MD -- CHAPTER 21: Risk factors for arterial thrombosis, Mary Cushman, MD, MSc, Barbara M. Alving, MD -- CHAPTER 22: Peripheral Arterial Disease, William R. Hiatt, MD -- CHAPTER 23: Thrombosis and Cancer, Frederick R. Rickles, MD, FACP, Mark Levine, MD, MSc -- CHAPTER 24: Thrombotic Thrombocytopenic Purpura, Joel L. Moake, MD -- CHAPTER 25: Heparin-Induced Thrombocytopenia, Theodore E. Warkentin, MD -- Part IV: Therapeutic Measures -- CHAPTER 26: Antithrombotic Agents, Charles W. Francis, MD -- CHAPTER 27: Blood Component And Pharmacologic Therapy of Hemostatic Disorders, Charles D. Bolan, MD, Harvey G. Klein, MD -- CHAPTER 28 : Thrombolytic Therapy, Victor J. Marder, MD -- CHAPTER 29: Topical Hemostatic Agents for Localized Bleeding, Mark R. Jackson, MD -- CHAPTER 30: Therapeutic Apheresis, Chelsea A. Sheppard, MD, Christopher D. Hillyer, MD -- CHAPTER 31: Vena Cava Filters, Christine L. Hann, MD, Michael B. Streiff, MD -- CHAPTER 32: Thrombosis Related to Venous Access Devices, McDonald K. Horne III, MD, Richard Chang, MD -- CHAPTER 33: Dietary Supplements and Hemostasis, Teirona Low Dog, MD, Merry-Jennifer Markham, MD -- Part V: Issues Specific to Women -- CHAPTER 34: Thrombotic Risk of Contraceptives and Other Hormonal Therapies, Suman Sood, MD, Steven Stein, MD, Barbara A. Konkle, MD -- CHAPTER 35: Management of Bleeding Disorders in Pregnancy, Stephanie Seremetis, MD, Vctoria Afshani, MD -- CHAPTER 36: Management of thrombophilia and APLS during pregnancy, Jody L. Kujovich, MD, Barbara M. Alving, MD -- Part VI: Special Issues -- CHAPTER 37: Surgery and Hemostasis, Craig S. Kitchens, MD -- CHAPTER 38: Anticoagulation in the Perioperative Period, Bundarika Suwanawiboon, MD, Thomas L. Ortel, MD, PhD -- CHAPTER 39: Hemostasis Alterations in Liver Disease and Liver Transplantation, M. Senzolo, MD, A.K. Burroughs, MD -- CHAPTER 40: Outpatient Anticoagulant Therapy, Jack E. Ansell, MD -- CHAPTER 41: Point of Care Testing for Hemostatic Disorders, Kendra Kubiak, MD, B. Gail Macik, MD -- CHAPTER 42: Prevention and Treatment of Venous Thromboembolism in Neurologic and Neurosurgical Patients, David Green, MD, PhD -- CHAPTER 43: Hematologic Interventions for Acute Central Nervous System Disease, Fred Rincon, MD, Andres Fernandez, MD, Stephan A. Mayer, MD -- CHAPTER 44: Atrial Septal Abnormalities and Cryptogenic Stroke, Peter C. Block, MD -- CHAPTER 45: Pulmonary Hypertension: Thrombotic and Non-Thrombotic in Origin, Lewis J. Rubin, MD -- CHAPTER 46:Hemorrhage Control and Thrombosis Following Severe Injury, Ann B. Zimrin, MD, John B. Holcomb, MD, John R. Hess, MD -- CHAPTER 47:Hemostatic Aspects of Sickle Cell Disease, Kenneth Ataga, MD, Richard Lottenberg, MD -- CHAPTER 48: Anticoagulation for Atrial Fibrillation and Prosthetic Cardiac Valves, Thomas G. DeLoughery, MD. |